{
  "abstract": "There are several scenarios within abortion care in which the measurement of serum beta-human chorionic gonadotropin (β-hCG) levels is useful or necessary. These include the management of pregnancy of unknown location, diagnosis of miscarriage or gestational trophoblastic disease, and confirmation that a medical abortion is complete as part of the protocol for very early medical abortion (VEMA). 1–4",
  "authors": [
    {
      "affiliations": [
        "Centre for Reproductive Health, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK",
        "Chalmers Sexual Health Centre, NHS Lothian, Edinburgh, UK"
      ],
      "name": "Jacqueline Quinn"
    },
    {
      "affiliations": [
        "Centre for Reproductive Health, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK",
        "Chalmers Sexual Health Centre, NHS Lothian, Edinburgh, UK"
      ],
      "name": "John Joseph Reynolds-Wright"
    },
    {
      "affiliations": [
        "Centre for Reproductive Health, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK",
        "Chalmers Sexual Health Centre, NHS Lothian, Edinburgh, UK"
      ],
      "name": "Karen McCabe"
    },
    {
      "affiliations": [
        "Chalmers Sexual Health Centre, NHS Lothian, Edinburgh, UK"
      ],
      "name": "Seonaid Boyle"
    },
    {
      "affiliations": [
        "Point-of-Care Test Group, NHS Lothian, Edinburgh, UK"
      ],
      "name": "Gordon Marr"
    },
    {
      "affiliations": [
        "Centre for Reproductive Health, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK",
        "Chalmers Sexual Health Centre, NHS Lothian, Edinburgh, UK"
      ],
      "name": "Sharon T Cameron"
    }
  ],
  "title": "Implementing a point-of-care test for β-human chorionic gonadotropin testing within an abortion service",
  "uid": "7a013b27-7460-5199-8bfa-bc1681d081b9"
}